Welcome to our dedicated page for Logan Ridge Finance SEC filings (Ticker: LRFC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fair-value marks on private first-lien loans, asset-coverage ratios and external management fees make Logan Ridge Finance Corp’s SEC disclosures a dense read. If you want Logan Ridge Finance Corp SEC filings explained simply or have waited hours for a Logan Ridge Finance Corp insider trading Form 4 transactions alert, you know the challenge.
Stock Titan removes that friction. Our platform ingests every document the moment it hits EDGAR—whether a 10-K, 10-Q or 8-K—and delivers AI-powered summaries you can grasp in minutes. Need the latest Logan Ridge Finance Corp quarterly earnings report 10-Q filing? It is already tagged, cross-linked and paired with concise analytics. Curious how portfolio markdowns affect NAV? See it alongside our Logan Ridge Finance Corp earnings report filing analysis. Real-time push notices surface Logan Ridge Finance Corp Form 4 insider transactions real-time, connecting executive moves to dividend history.
You’ll also find:
- Annual report clarity – the complete Logan Ridge Finance Corp annual report 10-K simplified with fair-value hierarchy tables decoded.
- Event monitoring – every Logan Ridge Finance Corp 8-K material events explained in plain language so nothing material slips by.
- Governance insight – the Logan Ridge Finance Corp proxy statement executive compensation broken down by fee structures and incentive metrics.
- Trade tracking – comprehensive views of Logan Ridge Finance Corp executive stock transactions Form 4 to spot buying or selling patterns.
Whether you’re comparing quarters, monitoring credit risk, or simply understanding Logan Ridge Finance Corp SEC documents with AI, Stock Titan supplies complete coverage, expert context and measurable time savings.
Evolent Health, Inc. (EVH) filed a Form 4 reporting an equity-based compensation grant to President Daniel J. McCarthy. On 07/01/2025 Mr. McCarthy received 44,767 Class A common shares in the form of restricted stock units (RSUs) under the Amended and Restated 2015 Omnibus Incentive Compensation Plan at an effective purchase price of $0.00. Following the award, his aggregate beneficial ownership increased to 433,771 shares.
The award vests on a staggered schedule: 34 % on 07/01/2026, and 33 % on each of 07/01/2027 and 07/01/2028. These RSUs represent the second portion of the annual grant cycle; issuance was contingent on shareholder approval of additional plan shares, which occurred at the 06/05/2025 annual meeting.
No derivative securities were reported, and the filing indicates direct ownership. The transaction neither involved open-market purchases nor sales; therefore, it does not immediately alter the public float but does expand future fully-diluted share count once the RSUs settle.